{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-25-001496","form_type":"8-K","ticker":"VSEE","cik":"0001864531","company_name":"VSEE HEALTH, INC.","filed_at":"2025-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.869612+00:00","generated_at":"2026-05-17T03:17:52.381325+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"VSee Health issues $133k secured note, terminates equity line with Dominion","bullets":["Issued $133,333.33 secured note for $120,000 (10% OID), 5% interest, matures May 20, 2026, non-convertible.","Note fully secured by all assets of VSee and its subsidiaries under amended security agreements.","Terminated Equity Purchase Agreement with Dominion effective October 18, 2025, ending the equity line.","Covenants prohibit variable-rate transactions and require most-favored-nation terms to investor.","Proceeds used for general corporate purposes; existing security agreements amended to include this note."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-25-001496","json":"https://secwatch.observer/filing/0001185185-25-001496.json","markdown":"https://secwatch.observer/filing/0001185185-25-001496.md","text":"https://secwatch.observer/filing/0001185185-25-001496.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1864531/000118518525001496/0001185185-25-001496-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1864531/000118518525001496/vsee8k102025.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:17:52.381325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"46cae556808ee02a9842ff38efee943fc7ebdca8","claim":"VSEE HEALTH, INC. incurred loan of $133,333.33 with an accredited institutional investor at 5% per annum maturing May 20, 2026.","evidence_excerpt":"the Company issued to the Investor a secured note in the aggregate principal amount of $133,333.33 (the “Note”) for a purchase price of $120,000. The Note bears interest at the rate of 5% per annum and matures on May 20, 2026.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000118518525001496/0001185185-25-001496-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$133,333.33"},{"label":"Counterparty","value":"an accredited institutional investor"},{"label":"Rate","value":"5% per annum"},{"label":"Maturity","value":"May 20, 2026"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}